Yijia Zeng

Central South University, Third Xiangya Hospital

Papers

4

Total Citations

46

H-Index

4

About

Dr. Yijia Zeng is a leading figure in the advancement of robotic-assisted minimally invasive surgery, with a particular focus on evaluating the clinical performance of China’s domestically developed “Micro Hand S” surgical robot. Dr. Zeng’s major contributions center on rigorous comparative studies that benchmark the Micro Hand S against the globally dominant da Vinci system. In a pivotal 2021 study (24 citations), Dr. Zeng used propensity score matching to compare short-term outcomes of Micro Hand S versus da Vinci robot-assisted total mesorectal excision, demonstrating the domestic system’s viability for complex oncologic procedures. This work was complemented by a 2020 analysis of right colectomy (11 citations) and a multi-centre randomized controlled trial on cholecystectomy (2022, 6 citations), collectively establishing the Micro Hand S as a safe, feasible alternative to both conventional laparoscopy and the da Vinci platform. Dr. Zeng’s impact extends beyond clinical trials; a 2025 bibliometric analysis (5 citations) mapped the technological evolution of laparoscopic surgical robotics from 1999 to 2023, providing a comprehensive roadmap for future innovation. Through this body of work, Dr. Zeng has been instrumental in validating and advancing China’s indigenous surgical robotics, offering cost-effective solutions to expand access to robotic surgery.

Research Focus

Key Achievements

4
H-Index
4
Papers
46
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
The Micro Hand S vs. da Vinci Surgical Robot-Assisted Surgery on Total Mesorectal Excision: Short-Term Outcomes Using Propensity Score Matching Analysis
24 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Central South University, Third Xiangya Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago